首页> 外文期刊>Biopharmaceutics and Drug Disposition >Induction of NRF2-mediated gene expression by dietary phytochemical flavones apigenin and luteolin
【24h】

Induction of NRF2-mediated gene expression by dietary phytochemical flavones apigenin and luteolin

机译:膳食植物化学黄酮芹菜素和木犀草素诱导NRF2介导的基因表达

获取原文
获取原文并翻译 | 示例
           

摘要

Apigenin (API) and luteolin (LUT) have been used as therapeutic agents in folk medicine for thousands of years. These compounds exert a variety of biological activities, including anticancer, antioxidant and antiinflammatory activities. This study investigated whether API and LUT could activate Nrf2-antioxidant response element (ARE)-mediated gene expression and induce antiinflammatory activities in human hepatoma HepG2 cells. The compounds did not exhibit any substantial toxicity at low doses (1.56-6.25 mu m). The induction of ARE activity was assessed in HepG2-C8 cells after treatment with low doses of API and LUT for 6 and 12h. It was found that the induction of ARE activity by these compounds at the higher doses was comparable to the effects of the positive control, SFN at a dose of 6.25 mu m. Exposure to the PI3K inhibitor LY294002 abolished ARE activation by both API and LUT, whereas the ERK-1/2 inhibitor PD98059 only decreased ARE activity induced by API. Both compounds significantly increased the endogenous mRNA and protein levels of Nrf2 and Nrf2 target genes with important effects on heme oxygenase-1 (HO-1) expression. API and LUT significantly and dose-dependently decreased the production of nitric oxide (NO), nitric oxide synthase (iNOS) and cytosolic phospholipase A2 (cPLA2), which were induced by the treatment of HepG2 cells with 1 mu g/ml of lipopolysaccharide (LPS) for 24h. The results indicate that API and LUT significantly activate the PI3K/Nrf2/ARE system, and this activation may be responsible for their antiinflammatory effects, as demonstrated by the suppression of LPS-induced NO, iNOS and cPLA2. Copyright (c) 2015 John Wiley & Sons, Ltd.
机译:芹菜素(API)和木犀草素(LUT)在民间医学中用作治疗剂已有数千年的历史了。这些化合物具有多种生物活性,包括抗癌,抗氧化剂和抗炎活性。这项研究调查API和LUT是否可以激活Nrf2-抗氧化反应元件(ARE)介导的基因表达并诱导人肝癌HepG2细胞的抗炎活性。该化合物在低剂量(1.56-6.25μm)下没有表现出任何实质性毒性。在用低剂量的API和LUT处理6和12h后,评估了HepG2-C8细胞中ARE活性的诱导。发现在较高剂量下这些化合物对ARE活性的诱导与在6.25μm剂量下阳性对照SFN的作用相当。暴露于PI3K抑制剂LY294002消除了API和LUT的ARE激活,而ERK-1 / 2抑制剂PD98059仅降低了API诱导的ARE活性。两种化合物均显着增加Nrf2和Nrf2靶基因的内源性mRNA和蛋白质水平,对血红素加氧酶1(HO-1)的表达具有重要影响。 API和LUT显着且剂量依赖性地降低了通过用1μg/ ml脂多糖处理HepG2细胞诱导的一氧化氮(NO),一氧化氮合酶(iNOS)和胞质磷脂酶A2(cPLA2)的产生( LPS)24小时。结果表明,API和LUT显着激活了PI3K / Nrf2 / ARE系统,并且这种激活可能是其抗炎作用的原因,如抑制LPS诱导的NO,iNOS和cPLA2所证明的。版权所有(c)2015 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号